Lyme disease is increasing in the U.S. due to warmer temperatures and an increase in the deer population (deer tics spread the disease). Cases doubled between 1991 to 2018.
Lyme disease is caused by bacteria. The initial infection presents with fever, headache, fatigue, muscle and joint aches, enlarged lymph glands, and a red rash (may look like a bull’s eye in some cases).
Diagnosis initially depends on a history of a tic bite in someone with a rash and/or the symptoms described. Blood tests can confirm the diagnosis, but they do not become positive for 4-8 weeks after the tic bite occurs.
Most patients recover completely after a course of antibiotics, but about 10-20% develop a post treatment Lyme disease syndrome (PTLDS).
After initial symptoms have gone away, patients with PTLDS have new symptoms such as fatigue, joint pain, memory loss, poor focus, and dizziness with elevated heart rate when standing up. It can last for months to years.
Why? No one knows for sure but possibilities include the bacteria or parts of it remains in the body after antibiotic treatment or an immune reaction to the bacteria results in autoantibodies (antibodies that attack certain tissues in the person’s body, e.g., the brain).
Although there is some disagreement about PTLDS, there is evidence for it from lab and imaging studies. For example, special brain scans show widespread brain inflammation and changes in the front part of the brain.
Also, two different autoantibodies are often found in these patients. There may also be increased blood levels of a protein found with inflammation.
Currently, there is no specific treatment for PTLDS. Experts say that providing a second round of antibiotics does not help. Instead, doctors try to treat the symptoms to improve patient comfort.
There is new research attempting to find preventive measures such as a vaccine or an oral medicine that kills the tic before it can cause an infection (the tic needs to be on the person’s body for at least 36 hours before introducing the bacteria into the patient).
This blog is based on an article on this topic by Anita Slomski in JAMA Network 2023; 330(12): 1124-1126.
Peter M. Hartmann, MD
Family Medicine & Psychiatry